128 related articles for article (PubMed ID: 22160580)
21. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
[TBL] [Abstract][Full Text] [Related]
22. Galectin-1 and galectin-3: plausible tumour markers for oral squamous cell carcinoma and suitable targets for screening high-risk population.
Aggarwal S; Sharma SC; Das SN
Clin Chim Acta; 2015 Mar; 442():13-21. PubMed ID: 25578395
[TBL] [Abstract][Full Text] [Related]
23. Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer.
Horváth J; Szabó A; Tar I; Dezső B; Kiss C; Márton I; Scholtz B
Pathol Oncol Res; 2018 Oct; 24(4):833-842. PubMed ID: 28861772
[TBL] [Abstract][Full Text] [Related]
24. Serum circulating human mRNA profiling and its utility for oral cancer detection.
Li Y; Elashoff D; Oh M; Sinha U; St John MA; Zhou X; Abemayor E; Wong DT
J Clin Oncol; 2006 Apr; 24(11):1754-60. PubMed ID: 16505414
[TBL] [Abstract][Full Text] [Related]
25. Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancer.
Ervens J; Fuchs H; Niemann VT; Hoffmeister B
J Craniomaxillofac Surg; 2008 Mar; 36(2):89-94. PubMed ID: 18243718
[TBL] [Abstract][Full Text] [Related]
26. Exploring a Novel Screening Method for Patients with Oral Squamous Cell Carcinoma: A plasma Metabolomics Analysis.
Enomoto Y; Kimoto A; Suzuki H; Nishiumi S; Yoshida M; Komori T
Kobe J Med Sci; 2018 Sep; 64(1):E26-E35. PubMed ID: 30282895
[TBL] [Abstract][Full Text] [Related]
27. The balance of serum IL-18/IL-37 levels is disrupted during the development of oral squamous cell carcinoma.
Ding L; Zhao X; Zhu N; Zhao M; Hu Q; Ni Y
Surg Oncol; 2020 Mar; 32():99-107. PubMed ID: 31983439
[TBL] [Abstract][Full Text] [Related]
28. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
29. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas.
Shan J; Sun Z; Yang J; Xu J; Shi W; Wu Y; Fan Y; Li H
Oral Dis; 2019 Jan; 25(1):97-107. PubMed ID: 30169911
[TBL] [Abstract][Full Text] [Related]
30. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
[TBL] [Abstract][Full Text] [Related]
31. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
[TBL] [Abstract][Full Text] [Related]
32. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
[TBL] [Abstract][Full Text] [Related]
33. Salivary MMP-9 in the detection of oral squamous cell carcinoma.
Peisker A; Raschke GF; Fahmy MD; Guentsch A; Roshanghias K; Hennings J; Schultze-Mosgau S
Med Oral Patol Oral Cir Bucal; 2017 May; 22(3):e270-275. PubMed ID: 28160595
[TBL] [Abstract][Full Text] [Related]
34. An insight into crystallization test: A neoteric approach for screening premalignant and malignant lesions.
Rawat G; Kureel K; Urs AB
J Cancer Res Ther; 2020; 16(3):440-444. PubMed ID: 32719248
[TBL] [Abstract][Full Text] [Related]
35. Midkine as a prognostic biomarker in oral squamous cell carcinoma.
Ota K; Fujimori H; Ueda M; Shiniriki S; Kudo M; Jono H; Fukuyoshi Y; Yamamoto Y; Sugiuchi H; Iwase H; Shinohara M; Ando Y
Br J Cancer; 2008 Aug; 99(4):655-62. PubMed ID: 18682710
[TBL] [Abstract][Full Text] [Related]
36. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
38. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
39. Measurement of ATP6V1C1 expression in brush cytology samples as a diagnostic and prognostic marker in oral squamous cell carcinoma.
Pérez-Sayáns M; Reboiras-López MD; Somoza-Martín JM; Barros-Angueira F; Diz PG; Rey JM; García-García A
Cancer Biol Ther; 2010 Jun; 9(12):1057-64. PubMed ID: 20404513
[TBL] [Abstract][Full Text] [Related]
40. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.
Shi J; Bao X; Liu Z; Zhang Z; Chen W; Xu Q
Theranostics; 2019; 9(4):920-931. PubMed ID: 30867806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
